Miriam Reyes

Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The private company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures.

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.